Human papillomavirus distribution in cervical tissues of different morphology as determined by hybrid capture assay and PCR

被引:31
作者
Nindl, I
Greinke, C
Zahm, DM
Stockfleth, E
Hoyer, H
Schneider, A
机构
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT DERMATOL,D-2300 KIEL,GERMANY
[2] UNIV JENA,DEPT MED STAT COMP SCI & DOCUMENTAT,D-6900 JENA,GERMANY
关键词
human papillomavirus (HPV); hybrid capture assay (HCA); polymerase chain reaction (PCR); virus load; HPV distribution;
D O I
10.1097/00004347-199707000-00002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Distribution of various types of genital human Papillomavirus (HPV) in smears from histologically classified cervical lesions was determined by hybrid capture assay (HCA) and was compared with a polymerase chain reaction (PCR) system using general primers (GP) in first and type specific primers (TS) in a second step. The overall agreement of high-risk HPV by HCA and the more sensitive GP/TS PCR was 80.6% (204 of 253, kappa value 0.6). Human Papillomavirus frequency by GP/TS PCR was 14-20% higher compared with HCA (p = 0.02-0.004) independent of morphology. Only one sample was positive by HCA and negative by GP/TS PCR. A significantly higher frequency was found using HCA and GP/TS PCR in smears from histologically proven cervical intraepithelial lesions (CIN) II/III compared with CIN I, tissues with minimal changes (metaplasia, cervicitis, or lack of glycogenization), or normal morphology (61% and 81% vs 8-15% and 24-34%, p less than or equal to 0.001). Semi-quantitative estimate of HPV DNA copies by CIP-PCR coincided with estimated virus load by quantitative HCA and was significantly higher in patients with CIN II/III compared with CIN I (p < 0.001). Thus, the GP-PCR may be used to monitor the amount of HPV DNA copies in clinical samples. A direct correlation between morphologic changes and HPV detection as well as virus load was found by HCA and the more sensitive GP/TS PCR.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 36 条
  • [1] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [2] PREDICTIVE VALUE OF HUMAN PAPILLOMAVIRUS TYPE FOR HISTOLOGICAL DIAGNOSIS OF WOMEN WITH CERVICAL CYTOLOGICAL ABNORMALITIES
    BURGER, MPM
    HOLLEMA, H
    PIETERS, WJLM
    QUINT, WGV
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6972) : 94 - 95
  • [3] HUMAN PAPILLOMAVIRUS TESTING BY HYBRID CAPTURE APPEARS TO BE USEFUL IN TRIAGING WOMEN WITH A CYTOLOGIC DIAGNOSIS OF ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE
    COX, JT
    LORINCZ, AT
    SCHIFFMAN, MH
    SHERMAN, ME
    CULLEN, A
    KURMAN, RJ
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (03) : 946 - 954
  • [4] TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS DNA IN ABNORMAL SMEARS AS A PREDICTOR OF HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA
    CUZICK, J
    TERRY, G
    HO, L
    HOLLINGWORTH, T
    ANDERSON, M
    [J]. BRITISH JOURNAL OF CANCER, 1994, 69 (01) : 167 - 171
  • [5] HUMAN PAPILLOMAVIRUS TESTING IN PRIMARY CERVICAL SCREENING
    CUZICK, J
    SZAREWSKI, A
    TERRY, G
    HO, L
    HANBY, A
    MADDOX, P
    ANDERSON, M
    KOCJAN, G
    STEELE, ST
    GUILLEBAUD, J
    [J]. LANCET, 1995, 345 (8964) : 1533 - 1536
  • [6] de Villiers E M, 1994, Curr Top Microbiol Immunol, V186, P1
  • [7] HUMAN PAPILLOMAVIRUS DETECTION BY HYBRID CAPTURE AND ITS POSSIBLE CLINICAL USE
    FARTHING, A
    MASTERSON, P
    MASON, WP
    VOUSDEN, KH
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1994, 47 (07) : 649 - 652
  • [8] HUMAN PAPILLOMAVIRUS DNA AND GENOTYPES - PROGNOSTIC FACTORS FOR PROGRESSION OF CERVICAL INTRAEPITHELIAL NEOPLASIA
    GAARENSTROOM, KN
    MELKERT, P
    WALBOOMERS, JMM
    VANDENBRULE, AJC
    VANBOMMEL, PFJ
    MEYER, CJLM
    VOORHORST, FJ
    KENEMANS, P
    HELMERHORST, TJM
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (02) : 73 - 78
  • [9] AN EVALUATION OF HUMAN PAPILLOMAVIRUS TESTING FOR INTERMEDIATE-RISK AND HIGH-RISK TYPES AS TRIAGE BEFORE COLPOSCOPY
    HATCH, KD
    SCHNEIDER, A
    ABDELNOUR, MW
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (04) : 1150 - 1157
  • [10] PERSISTENT GENITAL HUMAN PAPILLOMAVIRUS INFECTION AS A RISK FACTOR FOR PERSISTENT CERVICAL DYSPLASIA
    HO, GYF
    BURK, RD
    KLEIN, S
    KADISH, AS
    CHANG, CJ
    PALAN, P
    BASU, J
    TACHEZY, R
    LEWIS, R
    ROMNEY, S
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (18): : 1365 - 1371